AzTrials
AzTrials

Chronic PeriodontitisNCT05275192

Utilization of a Videoscope in Periodontal Regeneration

A study testing Videoscope-assisted periodontal regeneration minimally invasive surgery, Periodontal regeneration minimally invasive surgery and Guided tissue regeneration surgery in people with Chronic Periodontitis, run by University of Illinois Chicago at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Clinical and preclinical studies confirm that regeneration of supporting tissues of teeth lost due to periodontal disease can be achieved using the principles of minimally invasive surgery (MIS). Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Chronic Periodontitis
What is being tested?
Videoscope-assisted periodontal regeneration minimally invasive surgery, Periodontal regeneration minimally invasive surgery and Guided tissue regeneration surgery
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteUnited States
Study dates
1 May 2022to 31 Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • • Individual must be between the age of 18 and 70 years of age
  • ASA I or II systemically healthy subjects
  • Individuals presenting with at least 1 single or multirooted tooth with residual, isolated, interproximal bony defect with probing depths (PD) ≥ 6 mm, clinical attachment loss (CAL) ≥ 6mm, bleeding upon probing (BOP), and ≥ 2mm width of attached gingiva (WAG)
  • Radiographic evidence of interproximal alveolar bone loss, on existing (< 2 years old) dental radiographs of diagnostic quality taken at the COD
  • Vital tooth or previous root canal therapy with no signs/symptoms of pathology
  • Individuals with plaque scores ≤ 20%
  • English speaking subjects (Individual must be willing to follow all the study requirements and participate in the study procedures in its entirety and read, understand the informed consent form)

Who cannot join

  • Individuals not referred from the Predoctoral Periodontics Student Clinics
  • Uncontrolled systemic disorders such as hypertension, heart disease, bleeding disorders, metabolic bone diseases, autoimmune disorders, etc., that may influence cellular/healing status
  • Diabetics
  • Current smokers
  • Individual less than 18 years of age
  • Individuals with non-isolated, interproximal PD ≥ 4 mm extending to the facial/buccal and/or palatal/lingual tooth surfaces
Show all 14Show fewer
  • Teeth with Grade 2 or 3 mobility
  • Teeth with metal restorations such as a porcelain fused to metal crown (due to scattering of radiographic images)
  • Intrabony defects on dental implants
  • Individual who take medications known to affect host immunity or periodontal tissues (ex. steroids, antibiotics, phenytoin, etc.) in the previous 6 months
  • Individuals on chronic anti-platelet/anti-coagulant therapy
  • Oral pathologies other than periodontal disease (ex. periapical lesions of non-periodontal origin)
  • Subjects who may be pregnant based on a positive pregnancy test
  • Non-English speaking individuals

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Illinois, Chicago, College of Dentistry, Periodontics

    Chicago, Illinois, 60612

Other trials in United States

About this study

Official title: Utilization of a Videoscope to Improve Clinical Outcomes of Periodontal Regeneration. A Pilot Study

Clinical and preclinical studies confirm that regeneration of supporting tissues of teeth lost due to periodontal disease can be achieved using the principles of minimally invasive surgery (MIS). Although this therapeutic approach is well established in clinical settings and can rescue teeth with poor or questionable prognosis, MIS approaches often suffer from lack of predictability due to poor intraoral visibility of the bony lesion and inability to confirm thorough removal of etiological factors (plaque/calculus) on tooth surfaces. We seek to investigate whether improved visualization of the surgical field using an FDA approved videoscope (V) improves clinical outcomes. For this pilot study, N=50 (to attain 10/group) age, sex matched, systemically healthy subjects diagnosed with Stage III, Grade B periodontitis, formerly known as severe chronic periodontitis, will be randomly assigned to either the VMIS (Test), MIS (Control 1) or Guided Tissue Regeneration (GTR, Control 2) group. All periodontal therapy will be performed following the Standard of Care for periodontal regeneration to determine if utilization of the videoscope improves clinical and radiographic outcomes. We will examine bone fill using conventional digital periapical radiographs (PAR) and Cone Beam Computed Tomography (CBCT) imaging at 6 and 12 months compared to baseline and collect gingival crevicular fluid (GCF) to compare expression of growth factors and cytokines/chemokines during the healing period. This is a single center treatment study where subjects will be recruited from individuals seeking periodontal treatment at the Graduate Periodontics Clinic, UIC College of Dentistry (COD). Participation of all subjects will end after 12 months and will comprise 7 total visits.

Being tested
Videoscope-assisted periodontal regeneration minimally invasive surgery, Periodontal regeneration minimally invasive surgery, Guided tissue regeneration surgery
Keywords
Periodontitis, Minimally invasive surgery, Videoscope, Guided tissue regeneration, Stage III, Grade B periodontitis
Medical subject headings
Chronic Periodontitis, Periodontitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Videoscope-assisted periodontal regeneration minimally invasive surgeryDevice

    Use of a videoscope to improve visualization of periodontal defect during minimally invasive surgery

  • Periodontal regeneration minimally invasive surgeryProcedure or surgery

    Conventional periodontal regeneration minimally invasive surgery without use of a videoscope

  • Guided tissue regeneration surgeryProcedure or surgery

    Conventional guided tissue regeneration surgery for periodontal regeneration without use of a videoscope

Study groups in NCT05275192
Study groupRoleWhat they receive
Videoscope-assisted periodontal regeneration minimally invasive surgeryExperimentalVideoscope-assisted periodontal regeneration minimally invasive surgery - Test group
Receives: Device: Videoscope-assisted periodontal regeneration minimally invasive surgery
Periodontal regeneration minimally invasive surgeryActive comparatorPeriodontal regeneration minimally invasive surgery - Control Group 1
Receives: Procedure: Periodontal regeneration minimally invasive surgery
Guided tissue regeneration surgeryActive comparatorGuided tissue regeneration - Control Group 2
Receives: Procedure: Guided tissue regeneration surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical Attachment Level

    Measured in mm as the periodontal probing depth (PD) plus gingival recession (GR).

    Measured: 6 months

  2. Probing Depth (PD)

    Measured in mm as the distance from the gingival margin (GM) to the base of the gingival sulcus.

    Measured: 6 months

  3. Gingival Recession (GR)

    Measured in mm as distance of the gingival margin (GM) to the cemento-enamel junction (CEJ).

    Measured: 6 months

  4. Radiographic Bone Height (RBH)

    Measured in mm as the distance from the cemento-enamel junction (CEJ) to the base of the alveolar bone defect (ABD).

    Measured: 6 months

  5. Radiographic Bone Volume (RBV)

    Measured in cubic mm as the volume of bone from the alveolar crest (AC) to the base of the alveolar bone defect (ABD).

    Measured: 6 months

  6. Clinical Attachment Level

    Measured in mm as the periodontal probing depth (PD) plus gingival recession (GR).

    Measured: 12 months

  7. Probing Depth (PD)

    Measured in mm as the distance from the gingival margin (GM) to the base of the gingival sulcus.

    Measured: 12 months

  8. Gingival Recession (GR)

    Measured in mm as distance of the gingival margin (GM) to the cemento-enamel junction (CEJ).

    Measured: 12 months

  9. Radiographic Bone Height (RBH)

    Measured in mm as the distance from the cemento-enamel junction (CEJ) to the base of the alveolar bone defect (ABD).

    Measured: 12 months

  10. Radiographic Bone Volume (RBV)

    Measured in cubic mm as the volume of bone from the alveolar crest (AC) to the base of the alveolar bone defect (ABD).

    Measured: 12 months

Secondary outcomes (2)
  1. Gingival Crevicular Fluid (GCF) Growth Factor and Cytokine/Chemokine Levels

    Concentration of 24 cytokines, chemokines, and growth factors in gingival crevicular fluid (GCF) measured in pg/mL.

    Measured: 6 months

  2. Gingival Crevicular Fluid (GCF) Growth Factor and Cytokine/Chemokine Levels

    Concentration of 24 cytokines, chemokines, and growth factors in gingival crevicular fluid (GCF) measured in pg/mL.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Mar 2022
  2. Study start1 May 2022
  3. Primary completion30 Apr 2028 (estimated)
  4. Study completion31 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05275192
Sponsor's protocol ID
2021-1311
Status last verified
Oct 2025
First submitted
4 Feb 2022
Last updated
17 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Videoscope-assisted periodontal regeneration minimally invasive surgery, Periodontal regeneration minimally invasive surgery and Guided tissue regeneration surgery in people with Chronic Periodontitis, run by University of Illinois Chicago at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 17 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical Attachment Level (time frame: 6 months). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in